Globus Medical (GMED) Shareholder Sio Capital Management Lifted Holding; Reinhart Partners Position in Apache (APA) Has Cut by $1.93 Million as Share Value Declined

February 24, 2018 - By Pete Kolinski

Sio Capital Management Llc increased its stake in Globus Medical Inc (GMED) by 29.95% based on its latest 2017Q3 regulatory filing with the SEC. Sio Capital Management Llc bought 33,964 shares as the company’s stock rose 10.32% with the market. The institutional investor held 147,364 shares of the health care company at the end of 2017Q3, valued at $4.38M, up from 113,400 at the end of the previous reported quarter. Sio Capital Management Llc who had been investing in Globus Medical Inc for a number of months, seems to be bullish on the $4.62 billion market cap company. The stock decreased 1.18% or $0.57 during the last trading session, reaching $47.91. About 664,988 shares traded. Globus Medical, Inc. (NYSE:GMED) has risen 30.88% since February 24, 2017 and is uptrending. It has outperformed by 14.18% the S&P500.

Reinhart Partners Inc decreased its stake in Apache Corp (APA) by 7.17% based on its latest 2017Q3 regulatory filing with the SEC. Reinhart Partners Inc sold 42,945 shares as the company’s stock declined 7.72% while stock markets rallied. The institutional investor held 556,111 shares of the oil & gas production company at the end of 2017Q3, valued at $25.47M, down from 599,056 at the end of the previous reported quarter. Reinhart Partners Inc who had been investing in Apache Corp for a number of months, seems to be less bullish one the $13.76B market cap company. The stock increased 3.67% or $1.28 during the last trading session, reaching $36.13. About 8.08M shares traded or 96.09% up from the average. Apache Corporation (NYSE:APA) has declined 10.21% since February 24, 2017 and is downtrending. It has underperformed by 26.91% the S&P500.

Investors sentiment decreased to 1.38 in 2017 Q3. Its down 0.19, from 1.57 in 2017Q2. It worsened, as 18 investors sold GMED shares while 68 reduced holdings. 42 funds opened positions while 77 raised stakes. 64.77 million shares or 3.39% more from 62.65 million shares in 2017Q2 were reported. Pnc Fincl Grp accumulated 2,862 shares or 0% of the stock. Moreover, Thompson Davis Com Inc has 0.03% invested in Globus Medical, Inc. (NYSE:GMED) for 503 shares. Prudential Financial Incorporated stated it has 49,410 shares. Btim Corporation accumulated 375,341 shares or 0.17% of the stock. Menta Cap Limited Co holds 50,368 shares or 0.22% of its portfolio. Rice Hall James Assoc Ltd Liability has invested 0.76% in Globus Medical, Inc. (NYSE:GMED). Tudor Et Al accumulated 7,736 shares. 155,113 are held by Voya Investment Limited Liability. Royal Fincl Bank Of Canada holds 1.34M shares or 0.02% of its portfolio. Millrace Asset Gru holds 61,500 shares or 1.72% of its portfolio. Pennsylvania-based Ajo LP has invested 0.01% in Globus Medical, Inc. (NYSE:GMED). Old Natl Bank In reported 12,088 shares. 1.84M were accumulated by Dimensional Fund Advsr Limited Partnership. Oppenheimer Asset Management Inc has 9,140 shares. Moreover, Parallax Volatility Advisers LP has 0% invested in Globus Medical, Inc. (NYSE:GMED) for 10,337 shares.

Sio Capital Management Llc, which manages about $116.75M and $192.73M US Long portfolio, decreased its stake in Glaxosmithkline Plc (Call) (NYSE:GSK) by 13,113 shares to 100,000 shares, valued at $4.06M in 2017Q3, according to the filing. It also reduced its holding in Advanced Accelerator Applications Sa by 55,941 shares in the quarter, leaving it with 52,582 shares, and cut its stake in Puma Biotechnology Inc (NYSE:PBYI).

Among 15 analysts covering Globus Medical Inc (NYSE:GMED), 9 have Buy rating, 2 Sell and 4 Hold. Therefore 60% are positive. Globus Medical Inc had 45 analyst reports since August 3, 2015 according to SRatingsIntel. On Tuesday, September 26 the stock rating was initiated by Needham with “Hold”. The company was maintained on Tuesday, July 18 by Piper Jaffray. Canaccord Genuity maintained the shares of GMED in report on Thursday, August 3 with “Buy” rating. Piper Jaffray maintained Globus Medical, Inc. (NYSE:GMED) rating on Tuesday, January 9. Piper Jaffray has “Buy” rating and $50.0 target. The company was initiated on Wednesday, November 30 by Aegis Capital. The stock has “Buy” rating by Canaccord Genuity on Tuesday, September 19. On Wednesday, August 30 the stock rating was maintained by Oppenheimer with “Hold”. The firm earned “Perform” rating on Wednesday, November 9 by Oppenheimer. Oppenheimer maintained it with “Hold” rating and $32 target in Friday, May 5 report. The firm has “Underweight” rating given on Thursday, November 9 by Barclays Capital.

Investors sentiment increased to 1.05 in Q3 2017. Its up 0.31, from 0.74 in 2017Q2. It is positive, as 60 investors sold APA shares while 202 reduced holdings. 66 funds opened positions while 209 raised stakes. 348.95 million shares or 1.76% more from 342.91 million shares in 2017Q2 were reported. The Connecticut-based Altrinsic Limited Liability has invested 0.87% in Apache Corporation (NYSE:APA). Madison Hldg stated it has 0.24% of its portfolio in Apache Corporation (NYSE:APA). Whittier Of Nevada has 34,605 shares. Envestnet Asset Mngmt owns 72,558 shares. Reilly Advisors Ltd Company has 0.01% invested in Apache Corporation (NYSE:APA) for 874 shares. Baillie Gifford And Com holds 0.71% or 12.29 million shares. Indexiq Advsrs Ltd Company holds 0% or 1,351 shares in its portfolio. Cubist Systematic Strategies Ltd Llc has 1,399 shares for 0% of their portfolio. Institute For Wealth Mngmt Limited Liability Corp invested 0.16% in Apache Corporation (NYSE:APA). Addenda has 34,055 shares. Trillium Asset Mgmt Ltd has 0.31% invested in Apache Corporation (NYSE:APA) for 120,106 shares. Blb&B Advsrs Limited Liability reported 0.04% stake. Amer Group has invested 0.02% in Apache Corporation (NYSE:APA). Cap Glob owns 0.18% invested in Apache Corporation (NYSE:APA) for 12.96 million shares. Butensky Cohen Fincl Security Incorporated holds 1.1% or 27,130 shares in its portfolio.

Since December 13, 2017, it had 1 insider buy, and 0 insider sales for $120,064 activity.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>